Conduct market analysis for setting up a next-generation sequencing (NGS) facility at the Aga Khan University in Nairobi.

Provide a roadmap for how to best commercialize a disruptive ICD coding solution.

Evaluate the future of the company's Digital and Interactive Creative and Technical Services Division and recommend a new strategic direction for this facet of the business.

Formulate a three-year strategic marketing plan to improve KromaTiD visibility and engagement with key players in the US and European Cell and Gene Therapy sector. Secondly, identify additional market segments where opportunities exist for KromaTiD products and services.

Formulate a three year European go-to-market plan.

Create a marketing plan for RENA with a focus on brand awareness in North America.

Investigate the viability of establishing a center for sustainability and social innovation

Develop a comprehensive 3 year US market entry strategy for FastBreak Medical that develops a non-invasive wearable patch-like device for the detection of ELVO stroke.